(19)
(11) EP 2 849 724 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
29.08.2018 Bulletin 2018/35

(45) Mention of the grant of the patent:
11.07.2018 Bulletin 2018/28

(21) Application number: 13724779.7

(22) Date of filing: 15.05.2013
(51) International Patent Classification (IPC): 
A61K 9/00(2006.01)
A61K 31/445(2006.01)
A61K 9/08(2006.01)
A61K 31/167(2006.01)
A61P 1/14(2006.01)
(86) International application number:
PCT/EP2013/060013
(87) International publication number:
WO 2013/171252 (21.11.2013 Gazette 2013/47)

(54)

MEANS TO FACILITATE FOOD INTAKE AND FOOD RETENTION

VORRICHTUNG ZUR LEICHTEREN NAHRUNGSAUFNAHME UND -BEHALTUNG

MOYENS POUR FACILITER L'INGESTION D'ALIMENTS ET LA RÉTENTION D'ALIMENTS


(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 16.05.2012 EP 12075046

(43) Date of publication of application:
25.03.2015 Bulletin 2015/13

(60) Divisional application:
18182448.3

(73) Proprietor: Orexa B.V.
6525 ED Nijmegen (NL)

(72) Inventors:
  • BROEKKAMP, Christophorus, Louis, Eduard
    NL-6651 BG Druten (NL)
  • PEETERS, Bernardus, Wijnand, Mathijs, Marie
    NL-6651 BG Druten (NL)

(74) Representative: De Vries & Metman 
Overschiestraat 180
1062 XK Amsterdam
1062 XK Amsterdam (NL)


(56) References cited: : 
JP-A- 2008 094 743
US-A1- 2007 020 195
US-A- 6 103 257
   
  • JOSEP M ARGILÉS ET AL: "Optimal management of cancer anorexia-cachexia syndrome", CANCER MANAGEMENT AND RESEARCH, vol. 2, no. 1, 22 January 2010 (2010-01-22), pages 27-38, XP055069782, ISSN: 1179-1322
  • D. D. KLOTH: "New pharmacologic findings for the treatment of PONV and PDNV", AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, vol. 66, no. 1_Supplement_1, 1 January 2009 (2009-01-01), pages S11-S18, XP055044172, ISSN: 1079-2082, DOI: 10.2146/ashp080462
  • SARA K. STORY ET AL: "A Comprehensive Review of Evidence-Based Strategies to Prevent and Treat Postoperative Ileus", DIGESTIVE SURGERY, vol. 26, no. 4, October 2009 (2009-10), pages 265-275, XP055069330, ISSN: 0253-4886, DOI: 10.1159/000227765
  • S. TORFS ET AL: "Risk Factors for Equine Postoperative Ileus and Effectiveness of Prophylactic Lidocaine", JOURNAL OF VETERINARY INTERNAL MEDICINE, vol. 23, no. 3, May 2009 (2009-05), pages 606-611, XP055069779, ISSN: 0891-6640, DOI: 10.1111/j.1939-1676.2009.0311.x
  • BALFOUR JR D C ET AL: "Use of procaine hydrochloride by mouth for gastrointestinal disorders", GASTROENTEROLOGY, ELSEVIER, AMSTERDAM, NL, vol. 22, no. 2, 1 January 1952 (1952-01-01), pages 257-262, XP009192489, ISSN: 0016-5085
  • SILK A D ET AL: "The use of oral procaine in a case of 'lysol' poisoning", GASTROENTEROLOGY, ELSEVIER, AMSTERDAM, NL, vol. 23, no. 2, 1 January 1953 (1953-01-01), pages 301-303, XP009192488, ISSN: 0016-5085
  • Damien Mcnally ET AL: "Randomised, Double-Blind, Placebo-Controlled Study of a Single Dose of an Amylmetacresol/2,4-dichlorobenzyl Alcohol Plus Lidocaine Lozenge or a Hexylresorcinol Lozenge for the Treatment of Acute Sore Throat Due to Upper Respiratory Tract Infection", JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, vol. 15, no. 2, 2 April 2012 (2012-04-02), pages 281-294, XP055321266, CA ISSN: 1482-1826, DOI: 10.18433/J31309
  • Joy E Gaziano: "Evaluation and Management of Oropharyngeal Dysphagia in Head and Neck Cancer", CANCER CONTROL, vol. 9, no. 5, 1 September 2002 (2002-09-01), pages 400-409, XP055320401, US ISSN: 1073-2748
  • Joy Bardy ET AL: "A double-blind, placebo-controlled, randomised trial of active manuka honey and standard oral care for radiation-induced oral mucositis", BRITISH JOURNAL OF ORAL AND MAXILLOFACISL SURGERY, vol. 50, no. 3, 1 June 2011 (2011-06-01), pages 221-226, XP055321342, GB ISSN: 0266-4356, DOI: 10.1016/j.bjoms.2011.03.005
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).